Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
DOI:
https://doi.org/10.14739/2310-1210.2021.6.236247Keywords:
clinical course, outcomes, chronic heart failure, preserved ejection fraction, obesity, atrial fibrillationAbstract
Aim. To study the features of the clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction (CHFprEF) in overweight and obese patients with concomitant atrial fibrillation (AF).
Materials and methods. 248 overweight and obese patients with CHFprEF, aged 65.0 ± 11.0 years, 146 females (58.9 %) and 102 males (41.1 %) were examined. The first group consisted of 181 patients without concomitant AF, mean age 64.0 ± 11.0 years, 110 females (60.8 %) and 71 males (39.2 %). The second group included 67 patients with AF, mean age 67.9 ± 11.3 years, 36 females (53.7 %) and 31 males (46.3 %).
Results. Comorbid AF was associated with a more severe course of CHFprEF by the rating scale of clinical state (0.9 points), Borg scale (1.7 points), a significant predominance of orthopnea (by 16.6 %), night cough (by 27.9 %), cardiac asthma (by 27.2 %), low exercise tolerance (by 14.3 %), weakness (by 23.7 %), palpitations (by 72.9 %), edema of the feet (by 40.6 %), rapid weight gain (by 32.6 %), jugular venous distention (by 21.4 %), pathological third heart sound (by 16.7 %), percussion extension of the cardiac borders (by 41.4 %) and dullness over the lungs (28.9 %), moist rales (24.3 %), second sound with a loud pulmonic component (by 33.9 %), tachypnea (by 25.9 %), hepatomegaly (by 32.0 %) and ascites (by 13.6 %), increased risk of cumulative endpoint (by 2.7 times), five-year mortality (by 3.4 times) and rehospitalization (by 3 times) (P ˂ 0.001).
Conclusions. AF as the comorbidity in overweight and obese patients is associated with more severe clinical course of CHFprEF and worse five-year outcomes.
References
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G. A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J. P., Lettino, M., Lip, G., Pinto, F. J., Thomas, G. N., … ESC Scientific Document Group. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128
Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1, dodatok 1), 1-66. [in Ukranian].
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V. P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., Mebazaa, A., Lund, L., Ambrosio, G. A., Coats, A. J., Ferrari, R., Ruschitzka, F., Maggioni, A. P., & Filippatos, G. (2017). Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. European Journal of Heart Failure, 19(12), 1574-1585. https://doi.org/10.1002/ejhf.813
Zafrir, B., Lund, L. H., Laroche, C., Ruschitzka, F., Crespo-Leiro, M. G., Coats, A., Anker, S. D., Filippatos, G., Seferovic, P. M., Maggioni, A. P., De Mora Martin, M., Polonski, L., Silva-Cardoso, J., Amir, O., & ESC-HFA HF Long-Term Registry Investigators. (2018). Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. European Heart Journal, 39(48), 4277-4284. https://doi.org/10.1093/eurheartj/ehy626
Fenger-Grøn, M., Vinter, N., & Frost, L. (2020). Body mass and atrial fibrillation risk: Status of the epidemiology concerning the influence of fat versus lean body mass. Trends in Cardiovascular Medicine, 30(4), 205-211. https://doi.org/10.1016/j.tcm.2019.05.009
Li, Z., Zhao, H., & Wang, J. (2021). Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Frontiers in Cardiovascular Medicine, 8, Article 650278. https://doi.org/10.3389/fcvm.2021.650278
Pannone, L., Falasconi, G., Cianfanelli, L., Baldetti, L., Moroni, F., Spoladore, R., & Vergara, P. (2021). Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification. Journal of Clinical Medicine, 10(9), Article 1823. https://doi.org/10.3390/jcm10091823
Ma, C., Luo, H., Fan, L., Liu, X., & Gao, C. (2020). Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis. Brazilian Journal of Medical and Biological Research, 53(7), Article e9646. https://doi.org/10.1590/1414-431X20209646
Kim, I. C. (2021). Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Two Chronic Troublemakers. Heart Failure Clinics, 17(3), 377-386. https://doi.org/10.1016/j.hfc.2021.03.001
Pan, Y., Xu, L., Yang, X., Chen, M., & Gao, Y. (2021). The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases. Heart Failure Reviews. https://doi.org/10.1007/s10741-021-10095-9
Nicoli, C. D., O'Neal, W. T., Levitan, E. B., Singleton, M. J., Judd, S. E., Howard, G., Safford, M. M., & Soliman, E. Z. (2021). Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction. Heart. https://doi.org/10.1136/heartjnl-2021-319122
(2020). Correction to: Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort. Circulation: Arrhythmia and Electrophysiology, 13(2), Article e000047. https://doi.org/10.1161/HAE.0000000000000047
Tian, H., Li, Y., Zhang, J., & Cheng, C. (2021). The effect of controlling the heart rate on the heart failure index and on heart function in heart failure patients with atrial fibrillation. American Journal of Translational Research, 13(4), 3487-3493.
Barillas-Lara, M. I., Monahan, K., Helm, R. H., Vasan, R. S., Schou, M., Køber, L., Gislason, G., Torp-Pedersen, C., & Andersson, C. (2021). Sex-Specific Prevalence, Incidence, and Mortality Associated With Atrial Fibrillation in Heart Failure. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2021.02.021
Dong, Z., Du, X., Lu, S., Jiang, C., Xia, S., He, L., Su, X., Jia, Z., Long, D., Sang, C., Tang, R., Liu, N., Bai, R., Yu, R., Dong, J., & Ma, C. (2021). Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study. BMC Cardiovascular Disorders, 21(1), Article 146. https://doi.org/10.1186/s12872-021-01951-5
Paolillo, S., Scardovi, A. B., & Campodonico, J. (2020). Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation. European Journal of Preventive Cardiology, 27(2 Suppl.), 27-34. https://doi.org/10.1177/2047487320960288
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
